These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Presence of bone-marrow- and neural-crest-derived cells in intimal hyperplasia at the time of clinical in-stent restenosis. Skowasch D; Jabs A; Andrié R; Dinkelbach S; Lüderitz B; Bauriedel G Cardiovasc Res; 2003 Dec; 60(3):684-91. PubMed ID: 14659814 [TBL] [Abstract][Full Text] [Related]
11. Spatial distribution of neo-intimal hyperplasia 6 months after zotarolimus-eluting stent implantation, analysed by optical coherence tomography. Souteyrand G; Levesque S; Ouchchane L; Sarry L; Eschalier R; Lusson JR; Motreff P Arch Cardiovasc Dis; 2011 Mar; 104(3):147-54. PubMed ID: 21497303 [TBL] [Abstract][Full Text] [Related]
12. Comparison of vascular response to zotarolimus-eluting stent versus sirolimus-eluting stent: intravascular ultrasound results from ENDEAVOR III. Miyazawa A; Ako J; Hongo Y; Hur SH; Tsujino I; Courtney BK; Hassan AH; Kandzari DE; Honda Y; Fitzgerald PJ; Am Heart J; 2008 Jan; 155(1):108-13. PubMed ID: 18082499 [TBL] [Abstract][Full Text] [Related]
13. Noninvasive angiographic evaluation of coronary stents with multi-slice spiral computed tomography. Nieman K; Cademartiri F; Raaijmakers R; Pattynama P; de Feyter P Herz; 2003 Mar; 28(2):136-42. PubMed ID: 12669227 [TBL] [Abstract][Full Text] [Related]
14. In-stent restenosis and multislice computed tomography: is the method ready to start? Martuscelli E; Razzini C; D'Eliseo A; Di Luozzo M; Mauro B; Romeo F J Cardiovasc Med (Hagerstown); 2007 May; 8(5):377-80. PubMed ID: 17443107 [TBL] [Abstract][Full Text] [Related]
15. A paclitaxel-eluting stent for the prevention of coronary restenosis. Park SJ; Shim WH; Ho DS; Raizner AE; Park SW; Hong MK; Lee CW; Choi D; Jang Y; Lam R; Weissman NJ; Mintz GS N Engl J Med; 2003 Apr; 348(16):1537-45. PubMed ID: 12700373 [TBL] [Abstract][Full Text] [Related]
16. Additional stenting promotes intimal proliferation and compromises the results of intravascular radiation therapy: an intravascular ultrasound study. Cheneau E; Wu Z; Leborgne L; Ajani AE; Weissman N; Pichard AD; Satler LF; Kent KM; Mintz G; Waksman R Am Heart J; 2003 Jul; 146(1):142-5. PubMed ID: 12851623 [TBL] [Abstract][Full Text] [Related]
17. Comparison of native coronary artery in-stent recurrence rates with longer versus shorter narrowings. Ahmed JM; Mintz GS; Waksman R; Pichard AD; Satler LF; Kent KM; Weissman NJ Am J Cardiol; 2002 Aug; 90(4):422-5. PubMed ID: 12161236 [No Abstract] [Full Text] [Related]
18. Randomized, double-blind, placebo-controlled trial of oral sirolimus for restenosis prevention in patients with in-stent restenosis: the Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) trial. Hausleiter J; Kastrati A; Mehilli J; Vogeser M; Zohlnhöfer D; Schühlen H; Goos C; Pache J; Dotzer F; Pogatsa-Murray G; Dirschinger J; Heemann U; Schömig A; Circulation; 2004 Aug; 110(7):790-5. PubMed ID: 15302787 [TBL] [Abstract][Full Text] [Related]
19. Neointimal hyperplasia and late pathologic remodeling in a porcine coronary stent model. De Scheerder I ; Wang K; Zhou XR; Verbeken E; Ping QB; Yanming H; Jianhua H; Szilard M; Van de Werf F J Invasive Cardiol; 1999 Jan; 11(1):9-12. PubMed ID: 10745430 [TBL] [Abstract][Full Text] [Related]
20. Role of probucol in inhibiting intimal hyperplasia after coronary stent implantation: a randomized study. Nunes GL; Abizaid AC; Theodoro MP; Brito FS; Caixeta A; da Silva LF; Mazzotti NG; Belló-Klein A; Clausell N Am Heart J; 2006 Nov; 152(5):914.e1-7. PubMed ID: 17070157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]